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Abstract 
Coarctation of the aorta is a congenital cardiac malformation that can go undiagnosed until old age with only hypertension 
as a marker of its presence because clinical signs can be subtle and overlooked if a complete physical exam is not performed.  
We report the case of a 45 year-old women, diagnosed with severe coarctation of the aorta just distal to the left subclavian 
artery, with poststenotic dilatation of the descending aorta and difficult control of blood pressure values. The patient was successfully 
treated interventionally, by balloon angioplasty with deployment of a covered stent. 
We review here the different methods employed for the treatment of coarctation of the aorta in adults, including surgical or 
percutaneous balloon angioplasty with or without stent placement, underlying their complications and the factors that influence the 
choice of the best coarctation repair method. 
 
Keywords: aortic coarctation, balloon angioplasty, covered stent, surgery. 
Adsas 
The incidence of coarctation of the aorta is 4 in 
10.000 live births, accounting for 5–8% of the children 
with congenital heart defects [1] 
Aortic coarctation presenting during adult life 
most frequently represents cases of re-coarctation, 
following previous transcatheter or surgical therapy, or 
missed cases of native coarctation. 
Without correction, the mean life expectancy of 
patients with aortic coarctation is 35 years and 90% of 
those patients die before reaching the age of 50 years. 
Systemic hypertension, accelerated coronary heart 
disease, stroke, aortic dissection, and congestive heart 
failure are common complications in patients who have 
not had surgery or who are operated on in later childhood 
or adult life. 
There are different methods employed for the 
treatment of CoA in adults, including surgical or 
percutaneous balloon angioplasty with or without stent 
placement, and medical therapy. 
 
Case presentation 
 
We report the case of a 45-year-old woman, 
diagnosed with arterial hypertension at the age of 39, with 
difficult control of blood pressure values under treatment 
with beta-blocker, ACE and diuretics, who was referred to 
us for evaluation. She had no history of cardiac problems 
or family history of hypertension. 
The clinical examination showed a normal body 
development, a blood pressure of 145/80 mmHg in the 
right arm and 135/80 mmHg in the left arm, large 
pulsations in the suprasternal notch, normal heart sounds, 
60 bpm. A systolic murmur was audible at the parasternal 
right and left area and at the paravertebral interscapular 
area bilaterally. The radial pulses were palpable but no 
pulse was found at the palpation of the femoral arteries or 
distal to that level.  
The electrocardiogram (Figure 1) showed sinus 
rhythm, QRS axis at +10, with no criteria for ventricular 
hypertrophy.  
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The chest X-ray shows a normal cardiothoracic 
index, visible azygos vein fissure, a high positioned aortic 
arch with a discreet ‘3’ sign (biarcuat appearance of the 
aortic arch) and no rib notching. (Fig. 2a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The laboratory tests showed only mild 
hypercholesterolemia, with otherwise normal urea and 
creatinine values, normal blood count and ionogram. 
At transthoracic echocardiography, which was 
otherwise unremarkable, from the suprasternal view, we 
found the signs of an aortic coarctation, with a peak 
systolic gradient of 69 mmHg at the coarctation site and 
diastolic run-off at Doppler evaluation; a hypoplastic 
abdominal aorta was also noted (13/15 mm) (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For clearly defining the location and anatomy of 
the coarctation, the patient underwent CT angiography 
examination that confirmed the presence of the 
coarctation just distal to the left subclavian artery, with 
poststenotic dilatation of the descending aorta, with very 
few collateral vessels (Figure 4) and a hipoplastic 
abdominal aorta. 
Fig. 1. Electrocardiogram. Sinus rythm, 62  bpm, without 
criteria for LVH. 
 
Fig. 2. Chest radiography. A Before stent placement and B  
After stent placement (see arrow for stent position) 
Fig. 3. A. Continuous Doppler echocardiography showing a 
peak systolic gradient of 69 mmHg and a low grade 
antegrade diastolic flow in the descending thoracic aorta 
(saw tooth), highly specific for significant aortic obstruction, 
before stent placement. B. Reduction of the peak systolic 
gradient at 29 mmHg after stent placement. Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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  Considering the presence of high gradient aortic 
coarctation in the presence of hypertension, corrective 
treatment was considered mandatory. The treating 
cardiologist – interventional cardiologist team, matching 
the patients’ preference, chose an interventional method. 
The patient underwent balloon angioplasty with stent 
placement. The femoral artery and vein were cannulated, 
the stenosis was passed with a probe and a guide, the 
pressure gradient across the coarctation segment was 
measured and found to be 70 mmHg, afterwards, a long 
sheat was introduced and a covered stent was positioned 
at the coarctation site. The stent was a stainless steel 
open cell stent balloon expandable laser cut 316L with a 
covering made of expanded PTFE on the interior and 
exterior aspects, with a 41 mm length and premounted on 
a 16 mm balloon. Rapid ventricular pacing at a frequency 
of 170 bpm was performed in order to provide transient 
decrease in cardiac output and aortic mobility, to achieve 
balloon stability. When the desired frequency and stability 
was obtained, the balloon was inflated and the stent fixed 
on the aortic wall. (Fig.5) The gradient was measured 
again and it was found to be less than 10 mmHg. 
 
 
 
 
 
 
 
 
 
 
Fig. 4. CT 3D images showing significant coarctation of the thoracic aorta beyond the origin of the left 
subclavian artery (arrow) with poststenotic dilatation and hypoplastic abdominal aorta. 
 
Fig. 5. A, B, C. Deployment of a 41 mm long 
coverd stent mounted on a 16 mm balloon at 
the coarctation site. The balloon is inflated 
progressively.  D. Aortography before stent 
placement (showing tight coarctation of the 
thoracic aorta just beneath the subclavian 
artery). E. aortography after stent placement.  
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Immediately after the stent placement, clinical 
reevaluation showed palpable pulses of the dorsalis 
pedis, posterior tibial, popliteal and femoral arteries and 
normal blood pressure with minimal treatment (decreased 
dose of beta blocker and ACE) was achieved during the 
following days. At echocardiography, from the 
suprasternal view, the proximal end of the stent that could 
be seen and the measured peak gradient at this level was 
of 29 mmHg.  
The patient was discharged three days after the 
procedure with recommendations for clinical and 
echocardiographic follow-up at 3 months and yearly 
afterwards, with an angioCT performed at 5 years 
intervals. Clopidogrel 75 mg for 3 months and aspirin for 6 
months were prescribed.  
At the 6-month follow-up visit, the clinical exam 
showed preserved lower-limbs pulses, the patient needed 
low doses of antihypertensive therapy; echocardiography 
showed a peak systolic gradient in the descending aorta 
of 27 mmHg.  
Discussion 
Coarctation of the aorta (CoA) is typically a 
discrete narrowing of the thoracic aorta just distal to the 
left subclavian artery. However, the constriction may be 
proximal to the left subclavian artery or rarely in the 
abdominal aorta. In some cases, coarctation presents as 
a long segment or a tubular hypoplasia [1]. The most 
frequently associated lesions include bicuspid aortic valve 
(up to 85% of the cases), different levels of aortic 
stenosis, mitral valve stenosis (parachute mitral valve, a 
complex known as Shone syndrome). Coarctation of the 
aorta imposes significant afterload on the LV, resulting in 
increased wall stress, compensatory LVH, LV dysfunction, 
and the development of arterial collaterals. Aortic 
coarctation presenting during adult life, most frequently 
represents cases of re-coarctation, following previous 
transcatheter or surgical therapy, or missed cases of 
native coarctation. Aortic coarctation may be recognized 
in the adult, usually because of systemic arterial 
hypertension and discrepant upper- and lower-extremity 
pulses. Patients may complain of exertional headaches, 
leg fatigue or claudication.  
The reduced life expectancy of patients without 
correction due to several complications like systemic 
hypertension accelerated coronary heart disease, stroke, 
aortic dissection, and congestive heart failure [4], demand 
an early treatment in these patients. 
 There  are  different methods employed for the 
treatment of CoA in adults, including surgical or 
percutaneous balloon angioplasty with or without stent 
placement, and medical therapy. 
The 2008 American College of 
Cardiology/American Heart Association (ACC/AHA) 
guidelines for adults with congenital heart disease 
(ACHD), recommend intervention for coarctation in the 
following circumstances [4]: peak to peak coarctation 
gradient greater than or equal to 20 mmHg, or peak to 
peak coarctation gradient less than 20 mmHg, in the 
presence of anatomic imaging evidence of significant 
coarctation with radiologic evidence of significant 
collateral flow (class IC indication). The peak-to-peak 
gradient is a measurement derived from catheterization 
data in which the peak pressure beyond the coarctation is 
subtracted from the peak pressure proximal to the 
coarctation, and is usually somewhat lower to the peak 
systolic gradient obtained by echocardiography. 
The European Society of Cardiology 2010 
guidelines for management of grown-up congenital heart 
disease say that all patients with a non-invasive pressure 
difference >20 mmHg between upper and lower limbs, 
regardless of symptoms but with upper limb hypertension 
(>140/90 mmHg in adults), pathological blood pressure 
response during exercise, or significant LVH, should have 
the intervention (class IC indication) [5]. 
Surgical repair of coarctation can be achieved by 
several techniques: resection with end-to-end 
anastomosis, subclavian flap aortoplasty in infants with 
long-segment coarctation, a bypass graft across the area 
of coarctation when the distance to be bridged is too long 
for an end-to-end repair or prosthetic patch aortoplasty 
[6]. Problems with these techniques have included a 
significant incidence of aneurysm formation with Dacron 
patch aortoplasty, and an unacceptably high recoarctation 
rate with the subclavian flap aortoplasty. The technique of 
extended end-to-end anastomosis appears to give good 
short-term to intermediate-term results with a low 
complication rate and has gained in popularity as the 
technique of choice when possible to use [7]. A 
complication associated with all the surgical techniques is 
aortic dissection, which can occur even late after surgical 
repair. Surgical mortality is rare (usually less than 1 
percent). Morbidity includes early postoperative 
paradoxical hypertension, left recurrent laryngeal nerve 
paralysis, phrenic nerve injury, and subclavian steal.   
Paraplegia due to spinal cord ischemia and mesenteric 
arteritis with bowel infarction are rare complications [2].  
Balloon angioplasty is a technique that was first 
introduced in 1982 and is currently being used either 
alone or along with stent deployment in the coarcted 
segment. Balloon angioplasty has been recommended as 
the preferred treatment for children and adults with native 
coarctation or recoarctation after surgery [8]. The initial 
success rate, defined as a gradient ≤ 20 mmHg across 
the coarctation, is approximately 80 to 90% in the largest 
studies. The major drawback of angioplasty alone is recoil 
of the vessel wall with recurrence of stenosis. Balloon 
angioplasty of the aorta can cause intimal and medial 
tears resulting in aortic wall dissection in 1–4% of 
patients, and aneurysm formation in 4–11.5% [1]. Shaddy 
et al compared the results of angioplasty with surgery in 
36 patients [9]. They concluded that the immediate Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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gradient reduction was similar in both modalities. 
However, there was an increased incidence of aneurysm 
formation and restenosis after balloon angioplasty. 
Following balloon dilation, approximately 21-37% of the 
patients remain hypertensive. 
Stenting of the aortic coarctation was first 
introduced in the early 1990s, using bare metal stents. 
When using this type of stents, the acute mortality rate is 
0-3%, whereas neurological complications have not been 
encountered [2]. Due to the large sheath sizes required, 
groin hematomas are prevented by the use of perclose 
and haemostatic devices, although interruption of the 
femoral and iliac vessels can occur during advancement 
of the long sheath. Acute aortic dissection and aneurysms 
following bare stent implantation may be seen in up to 
13% of the patients. Stent implantation may theoretically 
overcome some of the shortcomings of balloon dilatation, 
because the metal scaffolding may reduce the incidence 
of acute elastic recoil as well as late restenosis, due to a 
more complete elimination of gradient in the high-velocity 
arterial system flow [1]. Reduction or discontinuation of 
anti-hypertensive therapy following stent implantation is 
achieved in 41-88% of the patients.  
Hamdan  et al, reported the results of stent 
placement in 33/34 patients (13 native and 21 
recoarctation) [10]. All but one patient had a successful 
outcome following stent placement. Two patients 
underwent successful repeated stent dilation for 16–21 
months following the primary stent implantation. Six 
patients (18%) had complications including two patients 
who required surgery. The complications were 
retroperitoneal bleeding secondary to a high puncture (n = 
1), ruptured balloon segment embolization to the left 
axillary artery (n = 1), stent migration (n = 2) requiring 
additional stent placement, femoral arteriovenous fistula 
(n = 1), which resolved spontaneously. No patient 
developed an aneurysm. 
Covered stents have been extensively used 
outside the United States in order to address the 
problems associated with aortic wall injury by balloon 
angioplasty and “bare” stent placement. Covered stents 
are preferentially placed in patients where an aortic wall 
aneurysm exits, where a tight native coarctation is present 
and balloon or “bare” stent dilatation can be associated 
with the risk of dissection or rupture; where there is an 
associated arterial duct; and in older patients in whom the 
vessel wall is relatively less compliant. The limitations of 
using a covered stent are the larger sheath size and 
occlusion of the local branches of the aorta. Occlusion of 
the left subclavian artery is well tolerated; however, an 
intact vertebrobasilar system should be documented prior 
to the procedure [3]. The main risk is related to occlusion 
of spinal cord arteries, which can result in severe 
neurological complications like paraplegia. However, the 
spinal artery usually originates below the level of the ninth 
thoracic vertebra from the aorta below the diaphragm (in 
90% cases), therefore, spinal artery occlusion is unlikely 
to occur. However, operators should keep in mind that 
stent migration with fixation of the dislocated stent by 
redilation in a smaller distal area of the aorta as a rescue 
procedure might potentially occlude critical side branches 
that it crosses.  The covered stents are balloon-
expandable or self-expanding. Also the biodegradable 
stents are developing [11, 12]. 
In cases of a very tight coarctation of the aorta, a 
staged approach may be a safer option. For example, in 
an “hour glass” deformity, the stent is not fully expanded 
across the coarctation segment, and, as long as the stent 
is in a stable position, aggressive dilatation of the stent 
during initial deployment is not performed, instead, a 
staged approach is used, with a repeated balloon re-
dilatation of the same PTFE covered balloon mounted 
stent (or of a bear stent) with a repeated dilatation at 
intervals of 3 to 6 months. 
In addition, if a patient remains hypertensive with 
echo-Doppler findings that show substantial residual 
gradient, repeated dilatation of the stent is a feasible 
option.  
The choice of the best coarctation repair method 
is based on several factors. Stent implantation carries the 
lowest morbidity whereas repeat interventions are more 
common following endovascular treatment compared to 
surgery. In addition, the average duration of 
hospitalization following transcatheter therapy of aortic 
CoA is 48 hours, as compared to 5-14 days following 
surgical relief. Endovascular therapy is currently the 
treatment of choice when there is ventricular dysfunction 
or other significant comorbidity, such as diabetes, 
coronary disease, previous neurological insults, and in 
older patients with multiple comorbidities [2]. 
Medical treatment of the coarctation of the aorta 
is focused on hypertension. This should be controlled by 
beta-blockers, ACE inhibitors, or angiotensin-receptor 
blockers as first-line medications. The choice of beta-
blockers or vasodilators may be influenced in part by the 
aortic root size, the presence of aortic regurgitation, or 
both. [4,5] 
There are no studies to address the issue of 
antiplatelet therapy after percutaneous balloon 
angioplasty with stent placement, but it is considered 
cautious to recommend double antiplatelet therapy 
(aspirin and clopidogrel) for 3 months until a complete 
reendothelialization of the stent.    
Patients with uncomplicated native coarctation or 
uncomplicated, recurrent coarctation that is successfully 
repaired, do not require endocarditis prophylaxis unless 
there is a prior history of endocarditis or a conduit that has 
been inserted or if surgical repair or stenting has been 
performed less than 6 months previously.[4] 
Survival of patients with aortic coarctation has 
dramatically improved after surgical repair became 
available. However, survivors have decreased life 
expectancy and cardiovascular complications are 
frequent. Concern falls chiefly in seven categories: Journal of Medicine and Life Vol. 4, No. 2, April‐June 2011 
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recoarctation, aortic aneurysm formation or aortic 
dissection, coexisting bicuspid aortic valve, endocarditis, 
premature coronary atherosclerosis, cerebrovascular 
accidents and systemic hypertension. 
Furthermore, patients with apparently successful 
repair of coarctation of the aorta have increased proximal 
aortic stiffness that might contribute to the known 
significant cardiovascular mortality and morbidity. The 
increase in such large artery stiffness reduces the aortic 
reserve and creates stronger reflected waves, which, 
themselves, can lead to adverse left ventricular (LV) 
remodeling and functional disturbances. The effect of 
stenting on the proximal aortic elastic properties and its 
relation to cardiac structure and function in such patients 
was recently studied and abnormal proximal aortic 
properties with significant evidence of increased arterial 
wall stiffness before aortic stenting were demonstrated; 
that is why they remained unchanged afterwards despite 
the successful relief of downstream obstruction. However, 
the study showed a significant decrease in the mass 
index and an improvement in long-axis function of the left 
ventricle, thus suggesting some degree of reverse 
remodeling within the few months after removal of the 
afterload.[13] 
Nowadays, it is generally accepted that these 
patients require indefinite follow-up by a cardiologist, 
specialized in the field of congenital heart disease. The 
frequency in which outpatient visits and tests should take 
place is highly dependent on the clinical history, the 
presence of associated cardiac anomalies, type of repair, 
and the patient’s blood pressure. [14] 
The guidelines [4] recommend that patients who have had 
surgical repair or percutaneous intervention for 
coarctation of the aorta should have at least a yearly 
follow-up and, the evaluation of the coarctation repair site 
by MRI/CT, should be performed at intervals of 5 years or 
less, depending on the specific anatomic findings before 
and after repair (Class I, Level of evidence C). Even if the 
coarctation repair appears to be satisfactory, late 
postoperative thoracic aortic imaging should be performed 
to assess for aortic dilatation or aneurysm formation. 
Magnetic  resonance imaging has a limited role in CoA 
after stent placement since the metallic artifact (or noise) 
prevents detailed evaluation of the aortic segment within 
the stent, despite adequate visualization  of the aorta 
proximal and distal to the stent. 
Taking into account that our patient was a 46 
year-old lady, with a tight native coarctation of the aorta 
(gradient of 70 mmHg) and poststenotic dilatation of the 
descending aorta, the implantation of a covered stent was 
the best choice in this case because of the high risk of 
dissection or rupture by using classic stenting.  
Conclusions 
The case presented best illustrates that coarctation of 
the aorta is a congenital cardiac malformation that can go 
undiagnosed until old age, having only hypertension as a 
marker of its presence, because clinical signs can be 
subtle and overlooked if a complete physical exam is not 
performed.  
Nowadays, different surgical and interventional types 
of treatment are available but this should be individualized 
for each patient and for each type of coarctation (native 
coarctation or recoarctation after surgical or interventional 
treatment).  
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